Antisense inhibition of AT1 receptor in vascular smooth muscle cells using adeno-associated virus-based vector

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 354-359

  Mohuczy, Dagmara ^a   Gelband, Craig H ^a   Phillips, M Ian ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin; Antisense; Calcium; Muscle, smooth, vascular; Protein, green fluorescent; Receptors, angiotensin; Recombinant adeno associated virus vector

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; VIRUS VECTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; CALCIUM; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; PHENYLEPHRINE; PHOTOPROTEIN; RECOMBINANT PROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME INHIBITION; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECEPTOR DOWN REGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPORTER GENE; TARGET CELL; VASCULAR SMOOTH MUSCLE; ADENO ASSOCIATED VIRUS; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CYTOLOGY; CYTOMEGALOVIRUS; DRUG ANTAGONISM; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; CALCIUM; CELL LINE; CELLS, CULTURED; CYTOMEGALOVIRUS; DEPENDOVIRUS; DNA, ANTISENSE; DNA, COMPLEMENTARY; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; PROMOTER REGIONS (GENETICS); RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 0032608898     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.354     Document Type: Article

References (25)

1. Timmermans PB, Smith RD. Angiotensin II receptor subtypes: selective antagonists and functional correlates. Eur Heart J. 1994;15(suppl D): 79-87.
2. Alderman MH, Mahavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. New Engl J Med. 1991;324; 1098-1104.
3. Waeber B, Nussberger J, Brunner HR. Angiotensin-converting enzyme inhibitors in hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press; 1995:2861-2872.
4. Johnston CI. Angiotensin receptor antagonists: focus on losartan. Lancet. 1995;346:1403-1407.
5. Phillips MI, Wielbo D, Gyurko R. Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes. Kidney Int. 1994; 46:1554-1556.
6. Wielbo D, Sernia C, Gyurko R, Phillips MI. Antisense inhibition of hypertension in the spontaneously hypertensive rat. Hypertension. 1995; 25:314-319.
7. 1 angiotensin receptor mRNA in spontaneously hypertensive rats. Am J Hypertens. 1997;10:56S-62S.
8. Tomita N, Morishita R, Higaki J, Aoki M, Nakamura Y, Mikami H, Fukamizu A, Murakami K, Kaneda Y, Ogihara T. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen. Hypertension. 1995;26:131-136.
9. Makino N, Sugano M, Ohtsuka S, Sawada S. Intravenous injection with antisense oligodeoxynucleotides against angiotensinogen decreases blood pressure in spontaneously hypertensive rats. Hypertension. 1998;31: 1166-1170.
10. Phillips MI. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension. 1997;29:177-187.
11. Iyer SN, Lu D, Katovich M, Raizada MK. Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Proc Natl Acad Sci U S A. 1996;93:9960-9965.
12. Martens JR, Reaves PY, Lu D, Katovich MJ, Berecek KH, Bishop SP, Raizada MK, Gelband CH. Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy Proc Natl Acad Sci U S A. 1998;95:2664-2669.
13. Muzyczka N, McLaughin S. Use of adeno-associated virus as a mammalian transduction vector. In: Gluzman Y, Hughes SH, eds. Current Communications in Molecular Biology: Viral Vectors. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1988:39-44.
14. Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka NA. 'Humanized' green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol. 1996;70:4646-4654.
15. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-236.
16. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
17. Eguchi S, Hirata Y, Imai T, Kanno K, Marumo F. Phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology. 1994;134:222-228.
18. Beck E, Ludwig G, Auerswald EA, Reiss B, Schaller H. Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene. 1982;19:327-336.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 1976;72:514-517.
20. Mohuczy-Dominiak D, Phillips MI. Adeno-associated virus vector as a highly efficient transporter of exogenous DNA into cells. FASEB J. 1996;10:A447.
21. Lin KF, Chao J, Chao L. Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension. 1995;26: 847-853.
22. Lin KF, Chao L, Chao J. Prolonged reduction of blood pressure with human nitric oxide synthase gene delivery. Hypertension. 1997;30(pt 1):307-313.
23. 1-R mRNA antisense. Hypertension. 1997;29:374-380.
24. Russell DW, Hirata RK. Human gene targeting by viral vectors. Nat Genet. 1998;18:325-330.
25. Wu P, Phillips MI, Bui J, Terwilinger EF. Adeno-associated viral vector mediated transgene integration in nondividing cells. J Virol. 1998;72: 5919-5926.